Podcasts about Prostate cancer

Dr. Geo speaks with cancer immunologist Matthew Halpert, PhD about Immunocine, a dendritic-cell platform that “double-loads” patient-specific tumor signals to trigger a strong, physiologic immune response. Discussion includes mechanism, prostate cancer cases, how it can complement ADT and focal radiation, eligibility, workflow, and access.Chapters00:00 How the Immune System Fights Prostate Cancer02:00 Why dendritic cells matter; generals vs NK/T “soldiers”07:00 The “double-loading” breakthrough and fail-safe concept14:00 Trials in difficult cancers; safety and early signals18:00 Prostate cases: CRPC responses; lesions regressing22:00 Combining with ADT and focal radiation; timing27:00 Critical need for viable tissue; preservation tips34:00 Patient journey: review → tissue + apheresis → 3 doses/6 weeks41:00 Peri-lymphatic delivery; what patients feel; follow-up/boosts49:00 Cost, access, insurance help; foundations; closing takeawaysKey TakeawaysDendritic cells orchestrate immunity; NK/T cells execute.Precision double-loading overcomes a built-in fail-safe to amplify activation.Tissue access and preservation are essential for a broad, personalized target set.Pragmatic combination care: ADT and selective radiation can create a therapeutic window and enhance antigen presentation.________________________

The More Sibyl Podcast Presents: 암 너머의 인간| The One with Dr. Andrew Roth — Men, Medicine, and Meaning: The Emotional Landscape of Prostate Cancer| Episode 31 (2025)What does it mean to live well, even in the face of illness? How do we care for those navigating both the physical and emotional realities of cancer?In this episode of The More Sibyl Podcast, we sit down with one of the pioneers of psycho-oncology, Dr. Andrew Roth, Professor Emeritus of Clinical Psychiatry at Weill Cornell Medical College and longtime attending psychiatrist at Memorial Sloan Kettering Cancer Center.Together, we explore the emotional ripple effects of a cancer diagnosis, how anxiety and shame often hide beneath stoicism, and why naming our fears can sometimes be the most courageous act of all. Dr. Roth introduces tools like the Distress Thermometer and MAX-PC (Memorial Anxiety Scale for Prostate Cancer), simple yet profound ways clinicians can detect emotional suffering early, before it turns into isolation. These tools, he explains, aren't just checklists; they're bridges that reconnect patients to language, to care, and to hope.But perhaps the most powerful insight from Dr. Roth is this: healing doesn't always mean cure. Sometimes it means learning how to live with uncertainty, reclaiming joy in moments that medicine can't measure, and building relationships that remind us we are more than our diagnosis.He speaks of the courage it takes for men to open up, for partners to listen without judgment, and for doctors to lead with empathy rather than ego. In sharing his own journey, from community organizing in Brooklyn to a lifetime of helping patients find meaning in the midst of uncertainty, Dr. Roth shows how emotional honesty can transform medical care and what it truly means to “live better” with illness.Whether you're a clinician, caregiver, patient, or loved one walking beside someone in pain, this conversation will leave you with a renewed understanding of how connection, courage, and curiosity can shape the way we heal and the way we live.Because healing, as Dr. Roth reminds us, isn't just medical. It's profoundly human.

“Food is Medicine” initiative urged—but progress is slow; Thymic peptide for cancer; What is “orthomolecular psychiatry”? Magnesium threonate for tinnitus; How screen time and social media are dumbing down our kids; The craving for alcohol may be programmed from our primate origins. 

AI has existed for decades, but modern deep learning is finally delivering precision decisions in clinic. Dr. Spratt details how ArteraAI's predictive biomarker—validated on long-term randomized data—can spare roughly two-thirds of eligible men from ADT without compromising outcomes. We unpack ADT's quality-of-life trade-offs, practical training and nutrition strategies to preserve muscle, and where AI is headed next (post-surgery models, higher-risk disease). You'll also hear a clear framework for shared decision-making so men are treated as people, not just numbers.Key Points✅ AI meets prostate cancer. ArteraAI, developed by Dr. Daniel Spratt's team, is now part of the NCCN guidelines—helping doctors know which patients truly benefit from hormone therapy.✅ Two-thirds can skip ADT. Long-term data from the RTOG 9408 trial show most men can avoid the side effects of hormone therapy without affecting outcomes.✅ Quality of life first. Treatments should improve survival or well-being—if they don't, they shouldn't be used.✅ Lifestyle still matters. Exercise, protein, and resistance training help men on ADT preserve muscle and energy.✅ The future is personalized. New AI models will soon guide therapy for higher-risk patients and integrate full-body health data for truly tailored care.⏱️ Time-Stamped Highlights00:00 – Why AI in prostate cancer now? From buzzword to bedside with ArteraAI.01:30 – Deep learning vs. “human-defined” inputs; beyond Gleason to hundreds of slide features.03:10 – Landmark validation: RTOG 9408 and how the model predicts who benefits from ADT.05:00 – ADT trade-offs: longevity vs. libido, energy, bone/muscle; treat only if it improves life or survival.07:15 – “Exercise is medicine”: the 10-minute rule, protein targets, and resistance training on ADT.09:00 – Current indication: primarily intermediate-risk (Gleason 7) men receiving radiation.10:45 – What's next: models for higher-risk and post-prostatectomy patients; shorter-course ADT questions.13:00 – “Black box” & explainability: why robust external validation matters for trust.15:10 – Access & coverage: ordering via online portal; CMS coverage; what patients can ask their doctors.17:20 – Shared decision-making: reduce PSA anxiety; treat the person, not the number.___________________________________

How do I keep my LDL low enough without compromising my brain and my liver?I read that fish oil can raise LDL cholesterol. Is this true?A questionable case study on pycnogenol

Reasons for nausea  My PSA was 4.0 six months ago, and now it's up to 4.55. What should I do?I have lupus and need to take Methotrexate. How can I protect my liver and immune system?The important relationship between vitamin D3 and K2

Dr. Hoffman continues his conversation with Dr. Geo Espinosa, one of America's foremost integrative urologists.

Dr. Geo Espinosa, one of America's foremost integrative urologists, dishes on men's urinary problems, natural support for testosterone, and prostate cancer. Lifestyle factors—diet, exercise, sleep and stress reduction—play an important role in all phases of urological health. Dr. Geo explains how he interacts with conventional urologists on the faculty of NYU Langone Medical Center where he practices. Why are men's urinary problems not just a matter of prostate size? How can natural strategies alleviate urinary difficulties without the need for surgery or drugs? Besides saw palmetto, what nutraceuticals can benefit men with urinary problems? Are there really natural herbal alternatives to testosterone? For men with prostate cancer who are under active surveillance, is there anything more that can be done to minimize their chance of eventually needing surgery or radiation? What nutraceuticals, vitamins and minerals have anti-prostate cancer potential?

Dr Akila Viswanathan speaks with Johns Hopkins Radiation Oncology and Molecular Radiation Sciences faculty in attendance at the 2025 American Society for Radiation Oncology Annual Meeting in San Francisco to review the conference and provide updates on how the information presented will impact patient care. Dr Sahaja Acharya discusses soft tissue sarcomas. Dr Daniel Song reviews a range of studies on prostate cancer. Dr Ana Kiess describes the current state of radiopharmacueticals.  Dr Lawrence Kleinberg updates the progress being made in the treatment of central nervous system malignancies.

Examining the claim that cabbage family vegetables are bad for the thyroid; Walmart announces sweeping move to reformulate its products without synthetic dyes, sketchy additives; Under Congressional questioning, Google admits to censoring contrary narratives on YouTube during Covid; Children garner psychological benefits from grandparent time; J&J fined nearly $1 billion in landmark talc baby powder lawsuit; Humans are among the few animals who can't make their own vitamin C—why that may be a good thing.

The More Sibyl Podcast Presents: 새로운 나 | The One With Mr. Roland Odeleye, Esq. – Redefining Survival: On Prostate Cancer, Purpose, and the Power of Openness |Episode 30 (2025)At five or six years old, Mr. Roland Odeleye walked miles through the chaos of Nigeria's 1966 military coup, guided by an inner compass that brought him home safely. That moment became a defining spark in his journey, from Bodija's fruit-filled streets to a life of purpose, advocacy, and resilience in the face of prostate cancer.In this deeply moving episode of The More Sibyl Podcast, I sit down with Mr. Roland Odeleye, a Nigerian-born patent attorney, nonprofit leader, and prostate cancer advocate, whose story redefines what it means to live with purpose after illness.From his joyful childhood in Bodija, Ibadan, surrounded by fruit trees and family warmth, to decades of service providing free prostate screenings in Nigeria, Mr. Odeleye's life reflects resilience rooted in community, faith, and knowledge. But when the advocate became the patient, his mission took on a new meaning.Diagnosed with prostate cancer in 2017, he chose active surveillance (regular checkups) instead of immediate surgery, leaning on his family and faith through the journey. Years later, when surgery became necessary, he faced the realities of recovery: physical limitations, emotional healing, and redefined manhood.In this candid conversation, he opens up about:Growing up in Ibadan and the lessons of love, diversity, and resourcefulness.Building a foundation that offered free prostate and cataract screenings across Oyo State.His prostate cancer journey, from diagnosis to surgery, and what “healing” really means.Honest reflections on manhood, quality of life, and faith after prostate surgery.Why he rejects the label “survivor” and calls himself “a man who lived through cancer and carries its legacy.”His ongoing mission to track and support men from his foundation's past medical outreaches.Mr. Odeleye's story is not one of mere survival, but a call to redefine strength through vulnerability, to talk openly about men's health, and to find purpose even in pain.Whether you're on a health journey, supporting a loved one, or seeking inspiration, listen in to be inspired by a story that blends courage, humor, faith, and service, and reminds us all that healing is not a destination, but a daily act of purpose. Because, as the Yoruba saying goes, ”T'aba Mọ Ọna A kò baje”: if we know the way, we won't get lost.

AP correspondent Jennifer King reports some health news regarding former President Joe Biden.

We are thrilled to welcome Professor Manu Ampim back to our classroom. A distinguished African historian and primary researcher, Professor Ampim is renowned for his groundbreaking discovery that the Willie Lynch letter was a fake. In his session, he will delve into the rich histories of Africa’s greatest leaders—kings, queens, and chiefs—revealing insights that will inspire and educate. Before Professor Ampim takes the mic, Paula Bryce Simms will share an important preview of an upcoming Prostate Cancer awareness panel that you won’t want to miss.Additionally, Dr. Ganaka Lagoke from Lincoln University will kick off the morning with a crucial update on the ongoing situation in the Sahel nations, a topic that demands our attention.See omnystudio.com/listener for privacy information.

Join the October Menopause Challenge: https://drgabriellelyon.com/forever-strong-menopause-challenge/Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comWhen you hear the word “radiation,” do you think of cancer, Chernobyl, or an airport scanner? In this powerful episode, Dr. Gabrielle Lyon sits down with Dr. Sanjay Mehta, a radiation oncologist, to completely redefine your understanding of radiation as a tool for medicine.Dr. Mehta reveals how modern technology has made radiation oncology incredibly precise, minimizing side effects for cancer patients. He also shares groundbreaking insights into the underutilized field of low-dose radiation therapy, a safe and effective treatment for common inflammatory conditions like arthritis, tendinitis, and plantar fasciitis. This conversation is a must-watch for anyone with chronic pain or a fear of radiation, offering a new path to health and healing.Chapter Markers0:00 - Intro0:42 - The biggest myths about radiation1:33 - Dr. Sanjay Mheta's introduction2:07 - Radiation as a treatment for prostate cancer3:41 - The side effects of surgery vs. radiation4:32 - The training of a radiation oncologist5:34 - Full-body scans and diagnosis7:48 - What is radiation?9:00 - The difference between medicine and poison10:50 - The electromagnetic spectrum12:21 - Ionizing vs. Non-ionizing radiation13:42 - How we are naturally exposed to radiation15:50 - The biggest myth about radiation18:50 - Hormesis and low-dose radiation21:10 - The evolution of radiation technology22:38 - Radiation in daily life (dentist X-rays)25:00 - Can all cancers be destroyed by radiation?26:43 - Why radiation doesn't always burn skin28:25 - How radiation treatment is planned32:27 - Side effects of prostate cancer surgery33:09 - Penile shortening and prostate surgery36:00 - The role of testosterone in prostate cancer38:37 - How radiation affects bodybuilders39:09 - Who is not a candidate for radiation?41:33 - Is radiation the standard of care for all cancers?42:32 - Debunking radiation fear (microwaves, etc.)44:38 - The airport scanner debate47:03 - Other sources of radiation exposure52:32 - Grounding and radiation54:40 - Low-dose radiation for musculoskeletal injuries55:50 - The history of low-dose radiation57:22 - The use of radiation in the 1800s59:42 - Cortisone vs. low-dose radiation for pain1:03:00 - Dr. Ma's personal story of treatment1:04:07 - The duration and protocol of low-dose radiation1:08:16 - Inflammation and low-dose radiation1:10:59 - The durability of radiation therapy1:12:00 - Reversal of disease1:17:22 - Radiation's effect on hip pain1:18:29 - Treating rheumatoid arthritis1:20:29 - Post-operative radiation1:22:11 - Low-dose radiation for Peyronie's disease1:24:42 - What's holding back adoption of this therapy in the US?1:26:45 - The future of low-dose radiation1:27:31 - How to book an appointment with Dr. Mehta1:28:09 - Closing RemarksWho is Dr. Sanjay Mehta? Dr. Sanjay Mehta has been treating cancer patients for over 25 years using state of the art radiation oncology technology. He is now successfully treating patients with arthritis, tendonitis, and plantar fasciitis with low dose radiation using proven European regimens. It is non invasive, painless, and covered by Medicare and most insurance plans.This episode is brought to you by:PaleoValley - Get 15% off automatically at

34:36- Gen. Jack Keane, a retired 4-star general, the chairman of the Institute for the Study of War and Fox News Senior Strategic Analyst Topic: Remembering October 7th attacks, ongoing peace talks 50:01- Hogan Gidley, Former National Press Secretary for the Trump campaign, former White House Deputy Press Secretary, and a Newsmax contributor Topic: Ongoing government shutdown, latest from the Trump administration 1:00:06- Dr. Gabriella Scala, Vice Chair of the Young Adults Auxiliary of Columbus Citizens Foundation Topic: Italian American Heritage Month 1:24:49- Mike Davis, Founder of the Article III Project, Former Law Clerk for Justice Neil Gorsuch, and Former Chief Counsel for Nominations for the U.S. Senate Committee on the Judiciary Topic: New SCOTUS term 1:33:54- Laine Schoneberger, Chief Investment Officer, Managing Partner, and Founder of Yrefy Topic: Latest from Yrefy 1:43:51- Alan Dershowitz, Harvard Law Professor Emeritus, host of "The DerShow," and the author of "The Ten Big Anti-Israel Lies: And How to Refute Them with Truth" and the new book "The Preventative State" Topic: Remembering the October 7th attacks, Illinois and Chicago suing the Trump administration 1:57:03- Pastor Corey Brooks, founder and Senior Pastor of New Beginnings Church of Chicago and founder and CEO of Project H.O.O.D. Communities Development CorporationTopic: The argument for the National Guard 2:03:25- Dr. Gil Lederman, Expert in Prostate Cancer and the host of "Radiosurgery New York with Dr. Gil Lederman" on AM 970 The Answer Topic: Remembering the October 7th attacksSee omnystudio.com/listener for privacy information.

In this episode of Your History Your Story, we are honored to have as our guest, my friend and former colleague, Patrick Walsh. Pat is not only an author, but also a prostate cancer survivor who has turned his personal journey into a mission of hope and advocacy. In our conversation, Pat will share what it was like to first hear his diagnosis, the emotions of denial, the challenges of surgery and recovery and how he came to write his book, “Still Smiling: A Conversation with a Prostate Cancer Survivor”. We'll also talk about the importance of early detection, support systems and addressing the psychological impact of the disease. Since writing his book, Pat experienced a recurrence of prostate cancer and will share how he faced that difficult news and subsequent treatments with focus, determination and hope.Music: "With Loved Ones" Jay Man Photo(s): Courtesy of Pat WalshThank you for supporting Your History Your Story!YHYS Patreon: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ YHYS PayPal: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YHYS: Stay in the know, join our mailing list: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ YHYS: Website, Blog & Social: ⁠⁠⁠⁠⁠⁠CLICK HERE⁠⁠⁠⁠⁠⁠#yhys #yourhistoryyourstory #history #storytelling #podcast #njpodcast #youhaveastorytoo #jamesgardner #historian #storyteller #blogger To purchase Pat Walsh's book:⁠⁠ ⁠⁠CLICK HERE

Can high-precision radiation change how we treat metastatic prostate cancer? In this episode, I'm joined by Ronald C. Chen, MD, MPH—radiation oncologist, national guideline author (AUA/ASCO), and clinical-trial leader with 170+ publications—to unpack stereotactic body radiation therapy (SBRT) for disease that has spread to lymph nodes, bones, and beyond. We get practical about who benefits, where SBRT shines, and how to balance treatment intensity with quality of life.SBRT offers highly focused, short-course radiation that can control limited (“oligo-”) metastatic prostate cancer and delay systemic therapy for many men. Dr. Chen explains when to treat individual nodes/bone lesions versus comprehensive nodal fields, how anatomy determines dose/fraction choices (often 3–5 treatments), and why modern SBRT sometimes reduces the need for concurrent hormone therapy. We cover salvage options after prior radiation (brachytherapy seeds, HIFU, cryo, repeat SBRT, or salvage prostatectomy), the role and limits of PSMA PET, fracture risk and bone health (DEXA), and the evolving data—including the large NRG-GU013 trial—for higher-risk disease. Throughout, we emphasize shared decision-making, realistic expectations, and considering clinical trials when data are evolving.00:00 – Can SBRT change metastatic prostate cancer care? Meet Dr. Ron Chen.01:00 – Disclaimer: Views are Dr. Geo's and guests'—independent of NYU Langone.07:00 – Recurrence scenarios: prostate-only, nodal, or bone/other; why catching early matters.12:00 – Five salvage options after prostate radiation: seeds (brachytherapy), HIFU, cryo, SBRT (focal or whole-gland), or salvage prostatectomy.19:00 – Nodal relapse: treat all pelvic nodes + ADT ± abiraterone vs. SBRT to a few nodes only—how patient priorities drive the plan.26:30 – Oligometastasis: SBRT alone can control disease for many men ~2+ years on average, delaying hormones.30:00 – Fractions: why 3–5 treatments is typical and how adjacent bowel/organ anatomy sets the pace.31:00 – SBRT in 2 fractions for select primary cases looks promising; high-risk SBRT under study (NRG-GU013).37:00 – Bone mets: SBRT preferred; understanding fracture risk (tumor size, dose, shrinkage).40:00 – DEXA before ADT; spine SBRT can spare the spinal cord with modern planning.48:00 – Clavicle/hilar nodes: SBRT near lung/heart/esophagus—safe with careful dose constraints.56:00 – Why clinical trials matter for “how long on hormones?” and other open questions.57:00 – Soft-tissue mets (liver/brain): SBRT can help, often alongside systemic therapy.59:00 – Parting advice: early detection, close follow-up, and hopeful trajectory of care.___________________________________

Topics discussed on today's show: Frank's Root Canal, Smelly Celeb, Peanuts Gang, Sports News, Science News, Birthdays, Mean Girls Day, History Quiz, Musicians and Pain, Glue Bones, Cosmic Illusion, Peacocks, Jane Goodall, Music News, Sleeping in a Sellers Home, National BF Day, Single Lisa, SOG: Mama No Likey, Spotify AI, Prostate Cancer, Shark Bites, People with Rabies, Probably White?, and Apologies.

1 out of 8 men will get prostate cancer, which means 7 of you are in the clear. I found out I have it in early June and tomorrow I'm having a radical prostatecomy... removal of the prostate. By the time many of y'all hear this, I'll be cancer-free. The procedure is farily routine, my friends and family are here for me and I live a charmed life. I'm relatively young, healthy with excellent health insurance. And let's not forget I'm devilishly handsome. Catching this early afforded me so many options to eradicate the cancer.  I'm using this episode as a call to action for you men to get your PSA levels checked! More filmmaking talk next week! FILMMAKER RETREAT JOSHUA TREE '26 - SAVE YOUR SPOT! Thursday, October 1st – Sunday, October 4th, 2026. Limit 15 Filmmakers. This will be our 5th year. Limit 15 filmmakers and only 14 spots remain so SIGN UP! ONLINE FILMMAKING COURSES - DIRECT WITH CONFIDENCEEach of my online courses come with a free 1:1 mentorship call with yours truly. Taking the Shadow course is the only way to win a chance to shadow me on a real shoot! DM for details. Want to level up your commercial directing game? MAGIC MIND - MY MENTAL PERFORMANCE EXILIR - SAVE w BRADY20Save hugely on Magic Mind with this link. — This link is the way.  TRIPPY Check out Frequency Caps to try some mushroom-based treats. I like the cocao cubes. The code is BRADY10. Also, if you're in LA, Frequency House hold ceremonies often. Thanks, Jordan My cult classic mockumentary, "Dill Scallion" is online so I'm giving 100% of the money to St. Jude Children's Hospital. I've decided to donate the LIFETIME earnings every December, so the donation will grow and grow annually. Thank you. "Respect The Process" podcast is brought to you by Commercial Directing FIlm School and True Gent, aka True Gentleman Industries, Inc. in partnership with Brady Oil Entertainment, Inc.

Did you know that Prostate Cancer is one of the most common cancers among men?  It is also the second leading cause of cancer death in men, behind only lung cancer. To raise awareness and learn more about prostate cancer, I had the pleasure to sit down with Dr. David Hepps of St. Clair Medical Group Urology. In this episode, we discuss practical steps men can take for early detection and better outcomes, as well as how St. Clair supports patients and families through collaborative care and quality-of-life considerations. We also review treatment options such as robotic surgery, active surveillance, and the BioProtect Balloon that helps protect healthy tissue during radiation treatment.  To  schedule an appointment with Dr. Hepps or another St. Clair Medical Group Urology provider, call 412-942-4100.   Thank you St. Clair Health for sponsoring this episode. To learn more about St. Clair Health,  visit https://www.stclair.org/ All episodes are available on Youtube at http://www.youtube.com/@Spillwithmejennyd as well as all the major audio platforms. Interested in being a guest or sponsor on Spill with Me Jenny D Show? Contact Kelli Komondor at kelli@k2creativellc.com To view previous episodes and fill out a disclaimer to be a guest Under Tell us Your Story visit...https://www.spillwithmejennyd.com/

Thabo shole-Mashao standing in for Clement Manyathela speaks with Andrew Oberholzer, CEO of the Prostate Cancer Foundation, to discuss the critical importance of prostate cancer screening, awareness, and proactive health management. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

Should men with prostate cancer get vaccinated? Every health decision feels weightier during treatment—including vaccines. In this episode, Dr. Stephen Petteruti takes an evidence-based look at vaccines during prostate cancer treatment, examining how common shots: COVID, flu, tetanus, pneumococcal, hepatitis, and shingles, affect the immune system when it's already under pressure.He explores which vaccines may strengthen the immune system, which may create unnecessary risks, and how these choices fit into a personalized plan for living well with prostate cancer.This episode is designed to empower men with knowledge, so they can make decisions with confidence and keep their focus on living stronger, longer. Tune in now: Should You Get Vaccines During Prostate Cancer Treatment? Enjoy the podcast? Subscribe and leave a 5-star review.Dr. Stephen Petteruti is a leading Functional Medicine Physician dedicated to enhancing vitality by addressing health at a cellular level. Combining the best of conventional medicine with advancements in cellular biology, he offers a patient-centered approach through his practice, Intellectual Medicine 120. A seasoned speaker and educator, he has lectured at prestigious conferences like A4M and ACAM, sharing his expertise on anti-aging. His innovative methods include concierge medicine and non-invasive anti-aging treatments, empowering patients to live longer, healthier lives.Website: www.intellectualmedicine.com Website: https://www.theprostateprotocol.com/ YouTube: https://www.youtube.com/@intellectualmedicine LinkedIn: https://www.linkedin.com/in/drstephenpetteruti/ Instagram: instagram.com/intellectualmedine Consultation: https://www.theprostateprotocol.com/book-a-consultation Store: https://www.theprostateprotocol.com/store Community: https://www.theprostateprotocol.com/products/communities/v2/fightcancerlikeaman/home    Disclaimer:  The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

(00:00) Zolak & Bertrand are joined by RJ Bell of Pregame.com to discuss the best bets for Week 4 of the NFL season.(11:00) Patriots HC Mike Vrabel announces that DC Terrell Williams has been diagnosed with prostate cancer.(23:00)The crew finishes up the day by hitting on a bunch of different Patriots thoughts. (34:23) We close out the show with the takeaways from today.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Prostate cancer is common- unfortunately even more common and often deadlier in Black men. Meet a patient who learned he didn't need treatment right away and how his team at The University of Kansas Cancer Center helped make the decision on when to have surgery.

In part 1 of this episode, Mr Rick Dunn talks about his experience dealing with Prostate Cancer. With September being Prostate Awareness Month, we talk about the importance of getting checked for Prostate cancer. Black Men are run a higher risk of getting Prostate Cancer, but if you have a family history of the cancer, early detection is the key to surviving.

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Dr. Lindsay Hampson discusses urinary incontinence and sexual dysfunction following prostate cancer treatment, emphasizing that both are common and treatable. She explains the different types of incontinence—stress, urge, mixed, and overflow—and outlines how understanding the cause helps guide treatment. Options include pelvic floor physical therapy, medications, surgical interventions like slings or artificial sphincters, and supportive devices. Dr. Hampson also reviews effective strategies for managing erectile dysfunction, such as oral medications, vacuum devices, injections, and penile implants. She highlights the importance of shared decision-making and reassures patients that even small symptoms can significantly affect quality of life and deserve attention. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40814]

Prostate cancer deaths have been climbing over the last decade in part due to confusion over who should be screened and treated. In part 1 of a three-part series on prostate cancer, host Sandra Lindsay speaks with Samir Taneja, MD, a trailblazer in urologic cancer innovation, to explore how modern diagnostics and treatments, such as the groundbreaking use of MRI technology, are transforming patient outcomes. As Northwell's senior vice president and system chair of urology, Dr. Taneja provides invaluable insights into the shifting landscape of prostate cancer care and the critical importance of early detection. Tune in to understand the vital steps needed to increase awareness and save lives. About Northwell Health Northwell Health is New York State's largest healthcare provider and private employer, with 21 hospitals, 850 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit http://bit.ly/2Z7iHFL and explore our many opportunities. Get more expert insights from leading experts in the field — Northwell Newsroom.  Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn. Interested in a career at Northwell Health? Visit the health system's job portal and explore our many opportunities.    

On this episode host Jonathan Chance talks with renowned Uro-oncologist Dr. Grgur Miric about the health benefits of exercise, especially if you are diagnosed with a disease like prostate cancer. On this episode Jonathan and Dr. Miric talk about:·       How exercise is good for fighting prostate cancer and other diseases. ·       Studies that support fighting disease through exercise·       Why early detection is so important when it comes to prostate cancer.·       Who is at greater risk for a prostate cancer diagnosis.Prostate Cancer Aware is grateful to the Jevan and Ruzanna Chimayan Foundation for their generous donation, which will help fuel our podcast to raise critical awareness about prostate cancer and the PSA test around the world.Prostate Cancer Aware is a copyrighted production. No content maybe rebroadcast or reproduced without the expressed written consent of the Friedman Sidrow Foundation. For more information about prostate cancer, the PSA test, men's health and Jonathan's inspiring new book Unaware, which is about his battle with prostate cancer. Visit our website at: https://www.iknowmypsa.org Email us at: https://www.iknowmypsa.org/contactus/ Follow Prostate Cancer Aware on social media at: Facebook - https://www.facebook.com/iknowmypsa Twitter - https://twitter.com/iknowmypsa or @iknowmypsa Thank you for listening! Remember, Stay Aware and Stay Healthy.™

In this heartfelt episode, I sit down with David and Veronica a husband and wife who bravely share their journey through prostate cancer. He opens up about the difficult decision to undergo surgery, the emotions that came with it, and the grief he and his wife faced together. She shares how her unwavering support became a source of strength, reminding us that love and partnership can be a powerful medicine.Their story is not just about illness, it's about resilience, vulnerability, and the courage to face life's hardest moments side by side. It's also a call to action for men everywhere: take your health seriously, get your prostate checked, and don't be afraid to lean on those who love you.Tune in to hear a raw, emotional conversation about love, grief, and healing in the face of prostate cancer.

On this episode of The Mark White Show, we shine a spotlight on prostate cancer, the second most common cancer among men. Dr. Benjamin Lowentritt, Director of Prostate Cancer Services at United Urology Group and a nationally recognized leader in advanced treatments, explains the importance of early detection, current treatment options, and promising new research. Prostate cancer survivor Bob Lane then shares his personal journey and how he now encourages other men through the SHARE Network. Together, they bring both the medical expertise and human perspective needed to inspire awareness, action, and hope for men and their families.

The Marie Keating Foundation is trying to raise awareness around prostate cancer, including how you now only need to take a blood test to check for it - “no bum hole needed”!To discuss further, Seán is joined by Henry McKean.

Prostate cancer is one of the most urgent health issues facing men in Pennsylvania, according to cancer advocates and survivors who are working to remove barriers to early detection.Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

On this Make A Difference Minute, I'm joined by Bob Lane, a prostate cancer survivor and patient advocate. When Bob was diagnosed, he faced the fear and uncertainty that so many men feel, but he chose to take action with the support of his doctors, family, and community. Today, he shares his story through the SHARE Network to encourage other men not to ignore their health. Bob's message is clear: get checked, listen to your body, and don't wait until it's too late. His journey shows that early detection and treatment can make all the difference, and that no one has to face prostate cancer alone. Sponsor: Thompson Roofing & Construction 256roofing.com

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Radiologist Dr. Julian Hong plains how stereotactic body radiation therapy (SBRT) is used to treat oligometastatic prostate cancer—cases where cancer has spread but only to a few limited sites. This approach targets small clusters of metastases with high-dose, image-guided radiation in five or fewer sessions. Hong reviews clinical trial evidence showing that adding focal radiation can improve outcomes, especially when all visible metastases are treated. He highlights the value of modern imaging, like PET scans, in identifying lesions and shaping personalized treatment plans. Studies suggest SBRT offers effective disease control with low toxicity and minimal impact on quality of life, making it a promising option for patients with limited metastatic spread. Series: "Prostate Cancer Patient Conference" [Health and Medicine] [Show ID: 40807]

Sean Hawley is back on Trap Talk for the 6th time—and he never disappoints!

In this episode, host Chris Duffin sits down with the legendary Clark Bartram—Marine veteran, National Fitness Hall of Fame inductee, and founder of the Maximized Man Elite program. Known as America's most trusted fitness professional, Clark has dedicated his life to inspiring men to reclaim their vitality, strength, and purpose—naturally and sustainably. Clark Bartram's journey in men's health and fitness is nothing short of remarkable. Once a U.S. Marine, Clark transformed his discipline and passion into a decades-spanning career—earning recognition as “America's most trusted fitness professional.” He's inspired millions through books, TV appearances, and elite coaching, notably with his Maximized Man Elite program, guiding men over 40 to reclaim vitality and strength naturally. At age 61, Clark faced a new test: a diagnosis of prostate cancer despite his peak condition. Rather than let it stop him, Clark became an advocate, founding the nonprofit “Check It Like a Man” to promote early screening and awareness. Clark Bartram: https://clarkbartramsystems.com Instagram: @clarkbartram   This episode of the ARCHITECT of RESILIENCE podcast is available on Apple, Spotify & YouTube, and is sponsored by: @marekhealth : Performance. Longevity. Optimization.

About 1 in 8 men will face a prostate cancer diagnosis. Early-stage prostate cancer often has no symptoms—so how should men approach screening and advocacy? What disparities do Black men experience that would negatively impact their outcomes? And what can we do about it? We spoke with Otis Brawley, MD, professor of oncology at Johns Hopkins, about the types of prostate cancer, key symptoms, when and how often to screen, and why access to equal treatment is essential for equal outcomes for Black men. He also explains metastatic castration-resistant prostate cancer and why advanced imaging like PSMA PET scans matters. Survivor David Diaz Sr., executive director of The Reluctant Brotherhood, also shares his story of diagnosis, treatment, and the power of support groups for men navigating prostate cancer. See omnystudio.com/listener for privacy information.

What if prostate cancer surgery meant fewer incisions, faster recovery, and more precise cancer control? Today I'm joined by Dr. Michael D. Stifelman, Chair of Urology at Hackensack University Medical Center and a pioneer in robotic surgery with 4,000+ robotic procedures. We unpack how single-port robotics, real-time margin assessment, and AI are reshaping outcomes—while protecting continence and erections.Dr. Stifelman traces robotics from the early-2000s “pioneer phase” (and heavy skepticism) to today's standard of care, explaining why reproducibility, visualization, and tissue-sparing dexterity made the difference. We compare surgery vs. radiation (and focal therapies), when each shines, and why sequencing often matters—especially in higher-risk disease. He shares emerging tech like single-port prostatectomy, intra-operative margin evaluation (e.g., Histo-style scanning), quantitative surgical analytics, and even remote robotic assistance. We also talk “trifecta” outcomes, the role of genomics in Gleason 7 decision-making, and why lifestyle medicine and optimizing the tumor micro-environment go hand-in-hand with any treatment.Time-Stamped Highlights00:00 – Why fewer incisions + faster recovery are now real in prostate surgery05:40 – Work–life changes that improved health (sleep, exercise, biking)09:10 – Open vs. robotic: why reproducibility (teachability) matters11:05 – Robotics adoption curve: from early resistance to mainstream19:05 – Outcomes today: continence and erections after modern surgery20:10 – “Yes, I'm a surgeon—and here's my bias.” Radical honesty with patients22:05 – Offering the full menu: surveillance, focal (HIFU/cryotherapy), surgery, SBRT, proton25:40 – High-risk (Gleason 8–9): why surgery-first can preserve options & avoid long ADT34:00 – Dexterity & visualization: why robots spare nerves with less trauma35:10 – Real-time margin assessment during surgery to reduce positives40:00 – The “trifecta” (cancer control, continence, erections) and patient priorities42:10 – Genomics to risk-stratify Gleason 7 and guide surveillance vs. treatment45:00 – Future: nerve activation mapping & fluorescence to “light up” cancer46:10 – Single-port prostatectomy: smaller access, faster return of function (select patients)49:00 – Quantifying surgery with analytics; tele-mentoring & remote console potential52:30 – How to find Dr. Stifelman & closing advice

UVA School of Nursing scientist Randy Jones will discuss a decision tool he developed to help prostate cancer patients make treatment choices. Created with support from a $2.2 million National Institutes of Health grant, the tool is a valuable guide for patients when starting, stopping, or altering cancer treatment. Jones also talks about what conversations are important to have for patients like Biden and what advice he would have for patients beginning prostate cancer treatment.

September is Prostate Cancer Awareness month, with the disease now the most common cause of death from cancer for men in Australia. Advocacy groups are pushing for greater awareness and regular testing for all men in the country, including those from a multicultural background. - Сентябрь — месяц осведомлённости о раке простаты. Это заболевание в настоящее время является самой распространённой причиной смерти от рака среди мужчин в Австралии.

Gert Attard joins the show to discuss his recent Cell publication looking at tumor transcriptome-wide expression classifiers in advanced prostate cancer.

There is a new treatment option available now that can precisely target prostate lesions with electrical pulses, while helping preserve sexual function and urinary control. Whether you or a loved one has prostate disease, or you are a urologist considering this technology for your practice, you will not want to miss today's discussion on this innovative new option. September is Prostate Cancer Awareness Month, so we have a special episode today to kick it off. We are excited to welcome the distinguished urologist, Dr. Spencer Krane, to the Prostate Health Podcast. Dr. Krane is the Chief of Urology at the US Department of Veterans Affairs in New Orleans, Louisiana. He specializes in personalized medicine for patients with urologic malignancies, aiming to use new biomarkers, genomic classifications, epigenetic signatures, and advanced imaging modalities, including MRI-guided prostate biopsies, to offer his patients individualized care that improves cancer outcomes while minimizing therapy side effects. Dr. Krane has published extensively in urologic journals, and his work was selected to provide guidelines for urologic care. He has 50 peer-reviewed articles in national and international journals and has presented his work internationally, from Chile and Rome to Taiwan, as well as across the United States. We are excited to welcome him today to share his experience with the innovative new NanoKnife system as a treatment option for men with prostate tumors.  It is exciting to see ongoing innovation in the technology we have available for men with prostate tumors. For the appropriate candidates, this minimally invasive option offers precise targeting of the lesion while helping preserve both sexual function and urinary control.  Pertinent disclosure for today's episode – Dr. Krane is a paid consultant for AngioDynamics, Inc., which manufactures and sells the NanoKnife System. The views, information, and opinions expressed in this podcast are solely those of Dr. Krane, and does not necessarily represent those of AngioDynamics, Inc., its affiliates, or subsidiaries.  Show Highlights: Dr. Krane reviews the concept of targeted focal therapy and explains what  the NanoKnife system is Who is an ideal candidate for irreversible electroporation with the NanoKnife system? The advantages and features of the NanoKnife system   Does prostate size or shape limit the candidacy for IRE with the NanoKnife system? Would prostate anatomies on the MRI or biopsy exclude a patient from NanoKnife therapy? Dr. Krane explains how long it takes to resolve the initial decrease in sexual ability after NanoKnife therapy.   Why many patients experience improved urinary function in the long term after having NanoKnife therapy Dr. Krane clarifies the time it takes to resolve the initial decrease in sexual ability after being treated with NanoKnife therapy.   Links:  Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd.  Get your free What To Expect Guide (or find the link on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on X and Instagram  Sign up for the Prostate Health Academy   You can access Dr. Pohlman's free mini-webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here.  

This week on Health Matters, Courtney talks with urologic oncologist Dr. Michael Feuerstein of Columbia and NewYork-Presbyterian The One, a new center for advanced care in Westchester, to discuss the importance of screening for prostate cancer. Dr. Feuerstein explains how blood tests work to detect prostate cancer, explores the latest advancements in treatment, and debunks common myths and misunderstandings about prostate health. ___Dr. Michael Feuerstein, MD, MPH, is the chief of urology at NewYork-Presbyterian Westchester and assistant professor in the Department of Urology at Columbia University Vagelos College of Physicians and Surgeons. Dr. Feuerstein is a board-certified urologist with over ten years of experience, specializing in minimally-invasive surgery for prostate, kidney, and bladder cancer. He received his medical degree and completed his urology residency training at Albany Medical Center. He completed a two-year fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center and received a master's degree in public health at the Columbia Mailman School of Public Health. Dr. Feuerstein's research focuses on improving quality of care and quality of life for patients diagnosed with urologic cancers. Dr. Feuerstein provides care at NewYork-Presbyterian The One, a state-of-the-art center for advanced care with doctors from Columbia in Westchester. The facility offers adult and pediatric care spanning more than 90 specialties and subspecialties, so patients can find the care they and their families need in one convenient location.___Health Matters is your weekly dose of health and wellness information, from the leading experts. Join host Courtney Allison to get news you can use in your own life. New episodes drop each Wednesday.If you are looking for practical health tips and trustworthy information from world-class doctors and medical experts you will enjoy listening to Health Matters. Health Matters was created to share stories of science, care, and wellness that are happening every day at NewYork-Presbyterian, one of the nation's most comprehensive, integrated academic healthcare systems. In keeping with NewYork-Presbyterian's long legacy of medical breakthroughs and innovation, Health Matters features the latest news, insights, and health tips from our trusted experts; inspiring first-hand accounts from patients and caregivers; and updates on the latest research and innovations in patient care, all in collaboration with our renowned medical schools, Columbia and Weill Cornell Medicine.To learn more visit: https://healthmatters.nyp.org

Welcome to another powerful episode of Navigating Cancer TOGETHER, hosted by Talaya Dendy.In this episode, we shine a spotlight on prostate cancer awareness, the critical issue of health disparities, and the vital importance of open conversations within the Black and African American community. Talaya is joined by a remarkable guest, Christopher Shaddock, a veteran and prostate cancer survivor who shares his powerful personal journey. From his unique experience living in Iceland to his candid discussion about the emotional and physical impacts of his diagnosis, Christopher's story is one of determination, advocacy, and hope.This episode is a must-listen for men, caregivers, and advocates who want to understand the unique challenges of a prostate cancer diagnosis and the power of sharing one's story and creating a domino effect.✨Highlights from the show:3:12 Christopher shares his unique experience living in Iceland9:49 Christopher's prostate cancer diagnosis story10:55 The emotional impact of diagnosis and treatment16:39 Side effects of prostate cancer treatment: what men should know24:34 Addressing health disparities and barriers for African American men30:25 The importance of support groups and advocacy32:23 The “domino effect” of sharing your story and inspiring othersTranscript: https://bit.ly/podscript171ResourcesThe Silent Killer - https://www.silentkillerdoc.comThe Ties That Bind - https://www.bluechildentertainment.com/the-ties-that-bind-crowdfundingZero Prostate Cancer - https://zerocancer.org/black-menRespond Study - https://www.respondstudy.org

What if prostate cancer treatment weren't months of daily radiation—but five ultra-precise sessions guided in real time by MRI? Today, Dr. Michael J. Zelefsky (Professor of Radiation Oncology, NYU Grossman School of Medicine) explains how MRI-LINAC and adaptive planning are redefining accuracy, reducing side effects, and personalizing care. A pioneer behind IMRT and image-guided radiotherapy, Dr. Zelefsky breaks down SBRT vs. IMRT, protons vs. photons, HDR brachytherapy, when to add hormone therapy, and how genomics + AI are shaping what's next.In this conversation, Dr. Zelefsky charts the evolution from long-course radiation to short-course SBRT with outcomes comparable to 7–9 week regimens—thanks to precision imaging and planning. He clarifies where IMRT ends and SBRT begins, why protons haven't shown superiority over photons in prostate cancer, and where HDR brachytherapy (Ir-192) shines—especially as a boost in higher-risk disease. We dig into dose equivalence (why 5×8 Gy can match ~80–90 Gy long-course), risk-based treatment + ADT duration, and how Decipher/Artera scores can refine decisions. Most exciting: MRI-LINAC with continuous motion monitoring keeps the prostate in a virtual “bullseye,” enabling whole-gland treatment with focal boosts today—and potentially true focal therapy tomorrow as biologic imaging and AI mature.Time-Stamped Highlights00:00 – Welcome 02:00 – Why Dr. Zelefsky's work is so respected; career arc and impact04:00 – What changed: CT/MRI planning → 3D-CRT → IMRT → SBRT12:45 – IMRT vs. SBRT: definitions, session counts, who gets what19:10 – Energy sources overview: photons, protons, brachytherapy20:30 – Protons vs. photons: evidence, indications, cost, access24:00 – HDR brachytherapy (Ir-192) as a temporary “in-and-out” boost28:00 – Dose logic: why 5×8 Gy (~40 Gy) ≈ long-course 80–90 Gy29:30 – Risk groups (low/intermediate/high) and when ADT is crucial33:00 – ADT durations (6–36 months): what trials actually showed37:00 – Genomics (Decipher/Artera): resolving risk discrepancies39:00 – What MRI-LINAC adds: real-time adaptive planning43:00 – Continuous Motion Monitoring (CMM): beam stops if target moves47:00 – Treat whole gland + boost the DIL (FLAME study approach)49:00 – Toward focal therapy with better biologic imaging + AI54:00 – How to choose: values, side-effects, lifestyle, comorbidities01:01:00 – Final guidance: don't be overwhelmed—multiple good option